Cargando…

A Transcription Factor-Based Risk Model for Predicting the Prognosis of Prostate Cancer and Potential Therapeutic Drugs

BACKGROUND: Prostate cancer (PC) is one of the most critical cancers affecting men's health worldwide. The development of many cancers involves dysregulation or mutations in key transcription factors. This study established a transcription factor-based risk model to predict the prognosis of PC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Ruixiang, Huang, Mengjun, Wang, Yinhuai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629613/ https://www.ncbi.nlm.nih.gov/pubmed/34853602 http://dx.doi.org/10.1155/2021/6894278

Ejemplares similares

Classification of pyroptosis patterns and construction of a novel prognostic model for prostate cancer based on bulk and single-cell RNA sequencing
por: Fu, Jianhan, et al.
Publicado: (2022)

A novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
por: Yang, Yanbing, et al.
Publicado: (2023)

Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
por: Qiu, Jun, et al.
Publicado: (2023)

Corrigendum: A Novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
por: Yang, Yanbing, et al.
Publicado: (2023)

Risk Factors for Postoperative Rebleeding and Short-Term Prognosis of Spontaneous Cerebellar Hemorrhage
por: Shen, Jun, et al.
Publicado: (2021)

A Novel Risk Factor Model Based on Glycolysis-Associated Genes for Predicting the Prognosis of Patients With Prostate Cancer
por: Guo, Kaixuan, et al.
Publicado: (2021)

Necroptosis Related Genes Predict Prognosis and Therapeutic Potential in Gastric Cancer
por: Wu, Nandie, et al.
Publicado: (2023)

A combined signature of glycolysis and immune landscape predicts prognosis and therapeutic response in prostate cancer
por: Guo, Tao, et al.
Publicado: (2022)

Transcription factors are potential therapeutic targets in epilepsy
por: Sun, Qihan, et al.
Publicado: (2022)

The Characteristics of Transcription Factors Regulating T Cell Exhaustion Were Analyzed to Predict the Prognosis and Therapeutic Effect in Patients with HCC
por: Li, Jingbo, et al.
Publicado: (2023)

Transcription Factors as Novel Therapeutic Targets and Drivers of Prostate Cancer Progression
por: Xie, Kangzhe, et al.
Publicado: (2022)

Construction and Verification of Risk Predicting Models to Evaluate the Possibility of Venous Thromboembolism After Robot-Assisted Radical Prostatectomy
por: Cheng, Xu, et al.
Publicado: (2022)

Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model
por: Thurtle, David R., et al.
Publicado: (2019)

Cancer-Associated Fibroblast Risk Model for Prediction of Colorectal Carcinoma Prognosis and Therapeutic Responses
por: Wang, Yan, et al.
Publicado: (2023)

Construction and validation of a fatty acid metabolism-related gene signature for predicting prognosis and therapeutic response in patients with prostate cancer
por: Zhao, Hongjun, et al.
Publicado: (2023)

Immune-related biomarker risk score predicts prognosis in prostate cancer
por: Liu, Zezhen, et al.
Publicado: (2020)

Anti-Transcription Factor RNA Aptamers as Potential Therapeutics
por: Mondragón, Estefanía, et al.
Publicado: (2016)

Transcription factors and potential therapeutic targets for pulmonary hypertension
por: Yang, Liu, et al.
Publicado: (2023)

Combining Lactate Dehydrogenase and Fibrinogen: Potential Factors to Predict Therapeutic Efficacy and Prognosis of Patients with Small-Cell Lung Cancer
por: Huang, Wen, et al.
Publicado: (2021)

Novel biomarkers predict prognosis and drug-induced neuroendocrine differentiation in patients with prostate cancer
por: Lin, Jingwei, et al.
Publicado: (2023)

UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer
por: Wang, Zijun, et al.
Publicado: (2020)

Perspectives for Forkhead box transcription factors in diabetic cardiomyopathy: Their therapeutic potential and possible effects of salvianolic acids
por: Han, Ronghui, et al.
Publicado: (2022)

Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer
por: Obinata, Daisuke, et al.
Publicado: (2017)

Pan-Cancer Analysis Predicts FOXS1 as a Key Target in Prognosis and Tumor Immunotherapy
por: Liu, Yunqiang, et al.
Publicado: (2022)

Analysis of factors potentially predicting prognosis of colorectal cancer
por: Jin, Li-Jun, et al.
Publicado: (2019)

Comprehensively analysis of splicing factors to construct prognosis prediction classifier in prostate cancer
por: Zhang, He, et al.
Publicado: (2023)

Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma
por: Jiang, Zhengsong, et al.
Publicado: (2023)

Telomere-related gene risk model for prognosis and drug treatment efficiency prediction in kidney cancer
por: Li, Song-Chao, et al.
Publicado: (2022)

Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma: Prediction of stage I HCC prognosis
por: Li, Zhiqiang, et al.
Publicado: (2022)

Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma
por: Huang, Changkun, et al.
Publicado: (2018)

Comprehensive Landscape of HOXA2, HOXA9, and HOXA10 as Potential Biomarkers for Predicting Progression and Prognosis in Prostate Cancer
por: Song, Yan-ping, et al.
Publicado: (2022)

Pim-3 is a Critical Risk Factor in Development and Prognosis of Prostate Cancer
por: Qu, Yanchun, et al.
Publicado: (2016)

The Effect of Transcription Factor MYB14 on Defense Mechanisms in Vitis quinquangularis-Pingyi
por: Luo, Yangyang, et al.
Publicado: (2020)

Primary non-Hodgkin’s lymphoma of the prostate with intractable hematuria: A case report and review of the literature
por: HU, SHANBIAO, et al.
Publicado: (2015)

Construction of a Prognostic Model for Predicting Colorectal Cancer Prognosis and Response to Immunotherapy Based on Cuproptosis-Associated lncRNAs
por: Yang, Yi, et al.
Publicado: (2023)

Smoothened is a poor prognosis factor and a potential therapeutic target in glioma
por: Tu, Yiming, et al.
Publicado: (2017)

Risk Predictive Model Based on Three DDR-Related Genes for Predicting Prognosis, Therapeutic Sensitivity, and Tumor Microenvironment in Hepatocellular Carcinoma
por: Hu, Renzhi, et al.
Publicado: (2022)

Characterization of the Estrogen Response Helps to Predict Prognosis and Identify Potential Therapeutic Targets in Cholangiocarcinoma
por: Lu, Chenglin, et al.
Publicado: (2022)

Role of GLI Transcription Factors in Pathogenesis and Their Potential as New Therapeutic Targets
por: Sabol, Maja, et al.
Publicado: (2018)

The regulatory mechanism and therapeutic potential of transcription factor EB in neurodegenerative diseases
por: Jiao, Fengjuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p38jiba3k96rgae7voeb6bupsm